课题基金 / 基金详情

IMPORTANCE OF ANTIBODY ISOTYPE IN VAGINAL HIV TRANSMISSION

IMPORTANCE OF ANTIBODY ISOTYPE IN VAGINAL HIV TRANSMISSION
抗体同种型在艾滋病毒阴道传播中的重要性
批准号:
8172982
负责人:
Ronald S. Veazey
金额:
$6.18万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2011-04-30

项目摘要

项目成果

Ronald S. Veazey的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. It is now clear that intestine and other mucosal tissues are of major importance in both the transmission as well as the early pathogenesis of HIV infection. These studies were initiated to determine if antibodies of different isotypes were better for protecting the vaginal vault, and performed experiments to determine if there was preferential secretion and we have now demonstrated that HIV-specific IgA and IgG are preferentially secreted from the intestine (rectum) and vagina, respectively following intravenous administration, and that following parenteral administration, up to 10ug/ml monoclonal antibodies can be detected in mucosal tissues 6-12 hr after administration to macaques. However, we could not detect sufficient IgA secretion in the vagina after parenteral administration, consistent with the hypothesis that IgA is produced in significant quantities in vaginal secretions. Although informative, this prevented the original study from completion and we have now switched directions to pursuing mechanisms of mucosal antibody protection, especially with MPER antibodies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vaccination with invariant MHC-II-linked accessory antigens for protection from HIV infection
  • 批准号:
    10687874
  • 项目类别:
  • 资助金额:
    $83.47万
  • 财政年份:
    2020
  • 负责人:
    Ronald S. Veazey
  • 依托单位:
Vaccination with invariant MHC-II-linked accessory antigens for protection from HIV infection
  • 批准号:
    10161562
  • 项目类别:
  • 资助金额:
    $79.09万
  • 财政年份:
    2020
  • 负责人:
    Ronald S. Veazey
  • 依托单位:
Evaluation of the Immunogenicity and Efficacy of HIV-1 SOSIP Envelope Protein Vaccine Delivered with or without Recombinant Viral Vector Vaccines
  • 批准号:
    10787977
  • 项目类别:
  • 资助金额:
    $111.02万
  • 财政年份:
    2020
  • 负责人:
    Ronald S. Veazey
  • 依托单位:
Vaccination with invariant MHC-II-linked accessory antigens for protection from HIV infection
  • 批准号:
    10463754
  • 项目类别:
  • 资助金额:
    $82.34万
  • 财政年份:
    2020
  • 负责人:
    Ronald S. Veazey
  • 依托单位: